Reading the "Risk Factors" in the From S-1 always proves to be educational. Thanks to the SEC the disclosures tend to be very candid (if not partially shrouded by legalese) and a good indicator of the structural weaknesses of a company.
For FitBit the lack of subscription revenue (1% of total), the litigation following product recalls, and the uncertainty from complying with FDA regulations seem particularly noteworthy.